AUC (SD) efter en enkeltdosis på 2 mg (4 mg i patienter med lever insufficiens) var 31, 4 ng/ ml x time (28, 3) i raske frivillige, 304, 9 ng/ ml x time (228, 0) i patienter med lever insufficiens, og 117, 9 ng/ ml x time (83, 8) i ældre type 2 diabetiske patienter.
The AUC (SD) after 2 mg single dose exposure (4 mg in patients with hepatic insufficiency) was 31.4 ng/ ml x hr (28.3) in healthy volunteers, 304.9 ng/ ml x hr (228.0) in patients with hepatic insufficiency, and 117.9 ng/ ml x hr (83.8) in the elderly type 2 diabetic patients.